Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00499_DB00730_nanopub.RAQE4jhV1DY-J0aT0q-s3qGpOYLqvRmFRVCVaWhyPU22U#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00499_DB00730 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00499_DB00730 label "DDI between Flutamide and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Flutamide by decreasing Flutamide metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Flutamide if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00499_DB00730]" assertion.
- drugbank_resource:DB00499_DB00730 identifier "drugbank_resource:DB00499_DB00730" assertion.
- drugbank_resource:DB00499_DB00730 title "DDI between Flutamide and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Flutamide by decreasing Flutamide metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Flutamide if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00499_DB00730 assertion.
- drugbank:DB00499 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00499_DB00730 assertion.